Enliven Therapeutics, Inc. <ELVN.O>: Jefferies raises target price to $69 from $59
ELVN•Related News
Gulf shipping traffic down after Houthis say they attacked Saudi tanker
XLE•
PIL partners with Celonis, WNS to expand process intelligence center of excellence
WNS•
NuScale Power Corp <SMR.N>: Canaccord Genuity cuts target price to $15 from $25
SMR•
Townsquare net loss widens to $41.8 million in Q2 FY26; revenue totals $115.4 million
TSQ•
Sunrun Inc <RUN.O>: JP Morgan cuts target price to $14 from $20
RUN•